BTB06584 is primarily utilized in research settings as a selective inhibitor of certain kinases, which are enzymes that play a critical role in cell signaling and regulation. Its application is particularly significant in the study of cancer biology, where it helps to elucidate the mechanisms of kinase activity in tumor growth and progression. By inhibiting specific kinases, BTB06584 can be used to investigate potential therapeutic targets for cancer treatment. Additionally, it serves as a valuable tool in pharmacological studies to understand the effects of kinase inhibition on cellular processes and to develop more effective and targeted drugs for various diseases.